Loading clinical trials...
Loading clinical trials...
Pooled Analysis of Multi-country, Open-label Single-arm, Non-interventional, Multi-center, Cohort Studies of Real-world Outcomes in New Users of Budesonide/Glycopyrronium/Formoterol (BGF) in Routine Care Setting
Conditions
Interventions
Budesonide/glycopyrrolate/formoterol fumarate
Locations
7
Canada
Research Site
Mississauga, Canada
Research Site
Hamburg, Germany
Research Site
Athens, Greece
Research Site
Milan, Italy
Research Site
Tokyo, Japan
Research Site
Bucharest, Romania
Start Date
April 17, 2025
Primary Completion Date
December 14, 2026
Completion Date
December 14, 2026
Last Updated
April 21, 2026
NCT06831994
NCT02755974
NCT05087641
NCT05050591
NCT05913765
NCT05592847
AstraZeneca Clinical Study Information Center
CONTACT
1-877-240-9479information.center@astrazeneca.comLead Sponsor
AstraZeneca
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions